Nikolaus Kneidinger

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 490 citations · Full text

Antifibrotic Therapy, Advanced Lung Disease, Idiopathic Pulmonary Fibrosis +6

Hypernatremia in the Critically Ill Is an Independent Risk Factor for Mortality

Gregor Lindner, Georg‐Christian Funk, Christoph Schwarz et al. · American Journal of Kidney Diseases · 2007 · 478 citations

Critical Care Medicine, Acute Care, Patient Safety +6

Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients

Valentin Fuhrmann, Nikolaus Kneidinger, Harald Herkner et al. · Intensive Care Medicine · 2009 · 204 citations

Critical Care Medicine, Hepatology, Viral Hepatitis +9

Activation of the WNT/β-Catenin Pathway Attenuates Experimental Emphysema

Nikolaus Kneidinger, Ali Önder Yildirim, Jens Callegari et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 193 citations

Coagulation parameters and major bleeding in critically ill patients with cirrhosis

Andreas Drolz, Thomas Horvatits, Kevin Roedl et al. · Hepatology · 2016 · 192 citations